Vol.

No.

March 02, 2018Mar 02, 2018

Free

DOWNLOAD THE PDF

Roche to acquire Flatiron Health for $2.1 billion, with focus on real-world data

Cover Story

Free

Roche to acquire Flatiron Health for $2.1 billion,

with focus on real-world data

By Matthew Bin Han Ong

Roche has signed an agreement to acquire all shares of Flatiron Health, a health care technology and services company headquartered in New York City, for $1.9 billion.

Conversation with The Cancer Letter Free

Roche CEO O'Day: Our investment in Flatiron will accelerate their mission

By Matthew Bin Han Ong

Conversation with The Cancer Letter Free

PH.AI CEO Hyde: With Big Data, pharma will focus on the measurement of value

By Matthew Bin Han Ong

Clinical Free Trials & Tribulations

A phase III trial seeks to determine whether diet and exercise can cure breast cancer

By Jennifer A. Ligibel

In Brief

Frederick Lab and Georgetown launch research, education collaboration

Yale joins BMS International Immuno-Oncology Network

Fung and the Fox Chase BMT Program receives “Game Changer Award”

MD Anderson and RaySearch form alliance to advance radiation therapy

Clinical Roundup

NCCN guidelines for patients with HIV seek to reduce cancer care gaps

CancerCare publishes findings from oncology provider study

A third of patients with lymph node-positive penile cancer don't receive recommended care

Drugs & Targets

Lilly receives additional FDA approval for Verzenio for advanced breast cancer

Yisheng's biological product for pancreatic cancer gets Orphan Drug Designation

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Roche to acquire Flatiron Health for $2.1 billion,

Roche CEO O'Day: Our investment in Flatiron will accelerate their mission

PH.AI CEO Hyde: With Big Data, pharma will focus on the measurement of value

A phase III trial seeks to determine whether diet and exercise can cure breast cancer

In Brief

Frederick Lab and Georgetown launch research, education collaboration

Yale joins BMS International Immuno-Oncology Network

Fung and the Fox Chase BMT Program receives “Game Changer Award”

MD Anderson and RaySearch form alliance to advance radiation therapy

Clinical Roundup

NCCN guidelines for patients with HIV seek to reduce cancer care gaps

CancerCare publishes findings from oncology provider study

A third of patients with lymph node-positive penile cancer don't receive recommended care

Drugs & Targets

Lilly receives additional FDA approval for Verzenio for advanced breast cancer

Yisheng's biological product for pancreatic cancer gets Orphan Drug Designation

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login